U.S. federal trademark · Serial No. 99259760
Research and development in the field of pharmaceuticals and biopharmaceuticals; Product development in the field of pharmaceutical and biopharmaceutical preparations, inserts being implantable intravitreal drug delivery devices, implants, and medicines; Development of pharmaceutical preparations and medicines; Product development in the field of pharmaceuticals and biopharmaceuticals
Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure, namely, ophthalmic pharmaceutical preparations that are delivered using implantable intravitreal drug delivery devices that are filled and sold with ophthalmic pharmaceutical preparations; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Pharmaceutical preparations for the treatment of eye diseases and conditions, namely, dexamethasone that is delivered using implantable intravitreal drug delivery devices that are filled and sold with dexamethasone; Pharmaceutical preparations for the treatment of post-op pain and inflammation of the eye, and itching associated with allergic conjunctivitis, namely dexamethasone that is delivered using implantable intravitreal drug delivery devices that are filled and sold with dexamethasone; Ophthalmic preparations
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.